CIK 1618205
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 63.60% | 52 |
| Technology Hardware & Equipment | 16.67% | 1 |
| Oil, Gas & Consumable Fuels | 4.89% | 2 |
| Unclassified | 4.46% | 8 |
| Machinery | 4.38% | 1 |
| Health Care Providers & Services | 2.56% | 3 |
| Health Care Equipment & Supplies | 1.66% | 3 |
| Life Sciences Tools & Services | 1.13% | 1 |
| Metals & Mining | 0.60% | 1 |
| Commercial Services & Supplies | 0.07% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | KLAC | KLA CORP | Information Technology | 16.67% |
| 2 | BMY | BRISTOL MYERS SQUIBB CO | Health Care | 10.57% |
| 3 | CMPX | Compass Therapeutics, Inc. | Health Care | 4.41% |
| 4 | LRCX | LAM RESEARCH CORP | Industrials | 4.38% |
| 5 | STOK | Stoke Therapeutics, Inc. | Health Care | 3.89% |
| 6 | OVV | Ovintiv Inc. | Energy | 3.63% |
| 7 | NTLA | Intellia Therapeutics, Inc. | Health Care | 3.25% |
| 8 | GPCR | Structure Therapeutics Inc. | Health Care | 2.74% |
| 9 | SLDB | Solid Biosciences Inc. | Health Care | 2.57% |
| 10 | PRTA | PROTHENA CORP PUBLIC LTD CO | Health Care | 2.48% |
65/73 names classified · sector 95.5% of weight · industry 95.5% · mkt cap 95.5%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 95.5% of the book is sector-classified (unclassified names shown, never dropped).
Only 46% of book weight classified — the grid is NOT representative of the whole book.
Classified: 46.1% of book weight (16/70 names) · unclassified 53.9%: CMPX, STOK, NTLA, GPCR, , SLDB, PRTA, BDSX, PTGX, OLMA +44 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | KLACKLA CORP | 19,883 | $29M | 16.7% | TRIM −9% |
| 2 | BMYBRISTOL-MYERS SQUIBB CO | 306,268 | $19M | 10.6% | HOLD |
| 3 | CMPXCOMPASS THERAPEUTICS INC | 1,465,867 | $8M | 4.4% | TRIM −8% |
| 4 | LRCXLAM RESEARCH CORP | 36,000 | $8M | 4.4% | TRIM −11% |
| 5 | STOKSTOKE THERAPEUTICS INC | 210,000 | $7M | 3.9% | TRIM −19% |
| 6 | OVVOVINTIV INC | 107,500 | $6M | 3.6% | HOLD |
| 7 | NTLAINTELLIA THERAPEUTICS INC | 445,400 | $6M | 3.3% | ADD 41% |
| 8 | GPCRSTRUCTURE THERAPEUTICS INC | 100,000 | $5M | 2.7% | ADD 11% |
| 9 | SLDBSOLID BIOSCIENCES INC | 625,980 | $5M | 2.6% | TRIM −11% |
| 10 | PRTAPROTHENA CORP PLC | 449,019 | $4M | 2.5% | HOLD |
| 11 | BDSXBIODESIX INC | 286,804 | $4M | 2.4% | HOLD |
| 12 | ACADACADIA PHARM | 171,000 | $4M | 2.2% | HOLD |
| 13 | PTGXPROTAGONIST THERAPEUTICS INC | 35,000 | $4M | 2.1% | TRIM −36% |
| 14 | NBIXNEUROCRINE BIOSCIENCES INC | 27,190 | $4M | 2.0% | HOLD |
| 15 | OLMAOLEMA PHARMACEUTICALS INC | 219,000 | $3M | 1.9% | TRIM −19% |
| 16 | RLMDRELMADA THERAPEUTICS INC | 409,387 | $3M | 1.6% | NEW |
| 17 | OCULOCULAR THERAPEUTIX INC | 320,000 | $3M | 1.5% | NEW |
| 18 | UTHRUnited Therapeutics Corp. | 4,500 | $3M | 1.5% | ADD 50% |
| 19 | NKTRNEKTAR THERAPEUTICS | 31,000 | $2M | 1.3% | HOLD |
| 20 | CLDXCELLDEX THERAPEUTICS INC NEW | 70,095 | $2M | 1.3% | NEW |
| 21 | NVCRNOVOCURE LTD | 202,330 | $2M | 1.3% | ADD 33% |
| 22 | EQTEQT CORP | 34,619 | $2M | 1.3% | HOLD |
| 23 | PHATPHATHOM PHARMACEUTICALS INC | 195,000 | $2M | 1.2% | HOLD |
| 24 | BCYCBICYCLE THERAPEUTICS PLC | 463,599 | $2M | 1.2% | HOLD |
| 25 | CMPSCOMPASS PATHWAYS PLC | 375,000 | $2M | 1.2% | NEW |
| 26 | PACBPACIFIC BIOSCIENCES CALIF IN | 1,500,000 | $2M | 1.1% | ADD 200% |
| 27 | CYTKCYTOKINETICS INC | 30,000 | $2M | 1.1% | HOLD |
| 28 | CORTCORCEPT THERAPEUTICS INC | 47,200 | $2M | 1.1% | TRIM −30% |
| 29 | VERAVERA THERAPEUTICS INC | 44,000 | $2M | 1.0% | HOLD |
| 30 | ALKSALKERMES PLC | 50,000 | $2M | 1.0% | HOLD |
| 31 | ENGENE HOLDINGS INC | 250,000 | $2M | 1.0% | NEW |
| 32 | QUREUNIQURE NV | 100,697 | $2M | 0.9% | ADD 227% |
| 33 | ZBIOZENAS BIOPHARMA INC | 70,000 | $1M | 0.8% | NEW |
| 34 | QUIDEL CORP | 82,548 | $1M | 0.8% | ADD 14% |
| 35 | FHTXFOGHORN THERAPEUTICS INC | 281,730 | $1M | 0.8% | HOLD |
| 36 | RAREULTRAGENYX PHARMACEUTICAL IN | 62,000 | $1M | 0.7% | HOLD |
| 37 | XENEXENON PHARMACEUTICALS INC | 21,000 | $1M | 0.7% | HOLD |
| 38 | KALVISTA PHARMACEUTICALS INC | 57,000 | $1M | 0.7% | HOLD |
| 39 | IMNMIMMUNOME INC | 50,000 | $1M | 0.6% | TRIM −62% |
| 40 | FCXFREEPORT MCMORAN INC | 18,040 | $1M | 0.6% | HOLD |
| 41 | AXSMAXSOME THERAPEUTICS INC. | 6,000 | $1M | 0.6% | HOLD |
| 42 | BIIBBIOGEN INC | 5,000 | $916,650 | 0.5% | NEW |
| 43 | LPCNLIPOCINE INC NEW | 111,786 | $893,170 | 0.5% | NEW |
| 44 | TVTXTRAVERE THERAPEUTICS INC | 29,200 | $867,532 | 0.5% | TRIM −32% |
| 45 | HROWHARROW INC | 24,000 | $846,240 | 0.5% | TRIM −29% |
| 46 | PHVSPHARVARIS N V | 29,847 | $843,178 | 0.5% | HOLD |
| 47 | VSTMVERASTEM INC | 150,000 | $795,000 | 0.5% | HOLD |
| 48 | APGEAPOGEE THERAPEUTICS INC | 9,000 | $757,530 | 0.4% | TRIM −44% |
| 49 | HALOHALOZYME THERAPEUTICS INC | 10,100 | $652,763 | 0.4% | HOLD |
| 50 | BBIOBRIDGEBIO PHARMA INC | 8,688 | $645,171 | 0.4% | HOLD |
| 51 | APELLIS PHARMACEUTICALS INC | 14,000 | $563,220 | 0.3% | HOLD |
| 52 | IDYAIDEAYA BIOSCIENCES INC | 16,860 | $561,775 | 0.3% | NEW |
| 53 | RCUSARCUS BIOSCIENCES INC | 25,889 | $559,202 | 0.3% | NEW |
| 54 | RGNXREGENXBIO INC | 66,270 | $555,343 | 0.3% | NEW |
| 55 | KPTIKARYOPHARM THERAPEUTICS INC | 83,952 | $467,613 | 0.3% | NEW |
| 56 | RCKTROCKET PHARMACEUTICALS INC | 127,025 | $454,750 | 0.3% | NEW |
| 57 | VRDNVIRIDIAN THERAPEUTICS INC | 20,100 | $393,156 | 0.2% | NEW |
| 58 | OMOUTSET MEDICAL INC | 98,882 | $379,707 | 0.2% | HOLD |
| 59 | LUNGPULMONX CORP | 250,221 | $322,785 | 0.2% | HOLD |
| 60 | CSTLCASTLE BIOSCIENCES INC | 12,900 | $316,695 | 0.2% | TRIM −84% |
| 61 | TRINTRINITY CAP INC | 20,000 | $294,200 | 0.2% | HOLD |
| 62 | CADLCANDEL THERAPEUTICS INC | 60,000 | $294,000 | 0.2% | HOLD |
| 63 | VYGRVOYAGER THERAPEUTICS INC | 74,918 | $289,183 | 0.2% | HOLD |
| 64 | CGEMCULLINAN THERAPEUTICS INC | 20,000 | $284,200 | 0.2% | HOLD |
| 65 | KBDCKAYNE ANDERSON BDC INC | 20,000 | $274,400 | 0.2% | HOLD |
| 66 | GRCEGRACE THERAPEUTICS INC | 50,000 | $231,500 | 0.1% | NEW |
| 67 | ELUTELUTIA INC | 165,094 | $173,349 | 0.1% | TRIM −37% |
| 68 | KYNBFIBROGEN INC | 22,566 | $152,997 | 0.1% | NEW |
| 69 | QNRXQUOIN PHARMACEUTICALS LTD | 20,000 | $132,000 | 0.1% | NEW |
| 70 | PHRPHREESIA INC | 14,300 | $119,834 | 0.1% | TRIM −87% |
| 71 | ZNTLZENTALIS PHARMACEUTICALS INC | 17,503 | $40,957 | 0.0% | ADD 3% |
| 72 | DCGODOCGO INC | 39,573 | $24,895 | 0.0% | TRIM −21% |
| 73 | GOSSGOSSAMER BIO INC | 18,176 | $5,971 | 0.0% | TRIM −87% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| KLACKLA CORP | — | — | 16K | 22K | 22K | 20K | $29M |
| BMYBRISTOL-MYERS SQUIBB CO | 1.4M | 685K | 323K | 317K | 303K | 306K | $19M |
| CMPXCOMPASS THERAPEUTICS INC | — | 24K | — | 873K | 1.6M | 1.5M | $8M |
| LRCXLAM RESEARCH CORP | — | — | — | — | 40K | 36K | $8M |
| STOKSTOKE THERAPEUTICS INC | 420K | 210K | 210K | 210K | 260K | 210K | $7M |
| OVVOVINTIV INC | 104K | 52K | 108K | 108K | 108K | 108K | $6M |
| NTLAINTELLIA THERAPEUTICS INC | — | — | 60K | 60K | 315K | 445K | $6M |
| GPCRSTRUCTURE THERAPEUTICS INC | — | — | 36K | 78K | 90K | 100K | $5M |
| SLDBSOLID BIOSCIENCES INC | — | 129K | 179K | 297K | 706K | 626K | $5M |
| PRTAPROTHENA CORP PLC | 609K | 333K | 451K | 549K | 441K | 449K | $4M |
| BDSXBIODESIX INC | 11.3M | 5.7M | 5.7M | 287K | 287K | 287K | $4M |
| ACADACADIA PHARM | 677K | 263K | 188K | 171K | 171K | 171K | $4M |
| PTGXPROTAGONIST THERAPEUTICS INC | 96K | 48K | 48K | 48K | 55K | 35K | $4M |
| NBIXNEUROCRINE BIOSCIENCES INC | 60K | 30K | 31K | 29K | 27K | 27K | $4M |
| OLMAOLEMA PHARMACEUTICALS INC | — | — | 134K | 174K | 269K | 219K | $3M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
